Gentian Diagnostics ASA GENT.OL Stock
Gentian Diagnostics ASA Price Chart
Gentian Diagnostics ASA GENT.OL Financial and Trading Overview
| Gentian Diagnostics ASA stock price | 36.2 NOK |
| Previous Close | 47.7 NOK |
| Open | 49 NOK |
| Bid | 45 NOK x N/A |
| Ask | 48.5 NOK x N/A |
| Day's Range | 49 - 49 NOK |
| 52 Week Range | 35 - 49.9 NOK |
| Volume | 1 NOK |
| Avg. Volume | 6.89K NOK |
| Market Cap | 755.7M NOK |
| Beta (5Y Monthly) | 0.539846 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.69 NOK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 52 NOK |
GENT.OL Valuation Measures
| Enterprise Value | 641.65M NOK |
| Trailing P/E | N/A |
| Forward P/E | -90.74074 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.172386 |
| Price/Book (mrq) | 4.9014707 |
| Enterprise Value/Revenue | 5.241 |
| Enterprise Value/EBITDA | -38.152 |
Trading Information
Gentian Diagnostics ASA Stock Price History
| Beta (5Y Monthly) | 0.539846 |
| 52-Week Change | 19.25% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 49.9 NOK |
| 52 Week Low | 35 NOK |
| 50-Day Moving Average | 44.57 NOK |
| 200-Day Moving Average | 41.43 NOK |
GENT.OL Share Statistics
| Avg. Volume (3 month) | 6.89K NOK |
| Avg. Daily Volume (10-Days) | 1.7K NOK |
| Shares Outstanding | 15.42M |
| Float | 7.43M |
| Short Ratio | N/A |
| % Held by Insiders | 53.72% |
| % Held by Institutions | 22.60% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -14.41% |
| Operating Margin (ttm) | -16.22% |
| Gross Margin | 54.22% |
| EBITDA Margin | -13.73% |
Management Effectiveness
| Return on Assets (ttm) | -6.40% |
| Return on Equity (ttm) | -10.94% |
Income Statement
| Revenue (ttm) | 122.43M NOK |
| Revenue Per Share (ttm) | 7.94 NOK |
| Quarterly Revenue Growth (yoy) | 45.50% |
| Gross Profit (ttm) | 59.29M NOK |
| EBITDA | -16818000 NOK |
| Net Income Avi to Common (ttm) | -17650000 NOK |
| Diluted EPS (ttm) | -1.15 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 76.02M NOK |
| Total Cash Per Share (mrq) | 4.93 NOK |
| Total Debt (mrq) | 11.32M NOK |
| Total Debt/Equity (mrq) | 7.34 NOK |
| Current Ratio (mrq) | 6.893 |
| Book Value Per Share (mrq) | 9.997 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5841000 NOK |
| Levered Free Cash Flow (ttm) | -11535375 NOK |
Profile of Gentian Diagnostics ASA
| Country | Norway |
| State | N/A |
| City | Moss |
| Address | Bjørnåsveien 5 |
| ZIP | 1596 |
| Phone | 47 99 33 99 05 |
| Website | https://www.gentian.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 55 |
Gentian Diagnostics ASA researches, develops, and produces biochemical reagents for use in medical diagnostics and research in Europe, Asia, and the United States. It offers in-vitro diagnostic reagents for clinical chemistry analyzers. The company's products include the gentian calprotectin immunoassay, a turbidimetric immunoassay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Cystatin C, a superior GFR marker for the diagnosis and therapeutic control of renal function; NT-proBNP Immunoassay for diagnosis, monitoring, and assessment of severity in individuals suspected of having congestive heart failure; and Canine c-reactive protein (CRP) immunoassay, a particle-enhanced turbidimetric immunoassay for quantitative determination of canine CRP in dog plasma and serum. It also provides turbidimetric SARS-CoV-2 total antibody immunoassay, a quantitative antibody test for detecting antibodies targeting the S1-subunit. Gentian Diagnostics ASA was incorporated in 2001 and is headquartered in Moss, Norway.
Q&A For Gentian Diagnostics ASA Stock
What is a current GENT.OL stock price?
Gentian Diagnostics ASA GENT.OL stock price today per share is 36.2 NOK.
How to purchase Gentian Diagnostics ASA stock?
You can buy GENT.OL shares on the Oslo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Gentian Diagnostics ASA?
The stock symbol or ticker of Gentian Diagnostics ASA is GENT.OL.
Which industry does the Gentian Diagnostics ASA company belong to?
The Gentian Diagnostics ASA industry is Medical Devices.
How many shares does Gentian Diagnostics ASA have in circulation?
The max supply of Gentian Diagnostics ASA shares is 15.42M.
What is Gentian Diagnostics ASA Price to Earnings Ratio (PE Ratio)?
Gentian Diagnostics ASA PE Ratio is now.
What was Gentian Diagnostics ASA earnings per share over the trailing 12 months (TTM)?
Gentian Diagnostics ASA EPS is -0.69 NOK over the trailing 12 months.
Which sector does the Gentian Diagnostics ASA company belong to?
The Gentian Diagnostics ASA sector is Healthcare.
Gentian Diagnostics ASA GENT.OL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Oslo Bors All-Share Index_GI OSEAX | 1017.37 NOK 97.59 USD |
+1.04
|
371.46M NOK 35.63M USD | 1003.3 NOK 96.24 USD | 1018.4 NOK 97.69 USD | — - | 371.46M NOK 35.63M USD |
- {{ link.label }} {{link}}